Therapy Areas: Cardiovascular
Cereno Scientific's Phase IIb trial of CS1 in PAH approved by US FDA
9 December 2025 - Cereno Scientific (Nasdaq First North: CRNO B), a Swedish biotech company developing treatments for rare cardiovascular and pulmonary diseases, announced on Monday that it has receiv...
InsiteOne agrees strategic partnerships with ASCEND Cardiovascular and Apollo Enterprise Imaging
1 December 2025 - InsiteOne, a provider of medical imaging data management and enterprise archiving solutions, announced on Sunday that it has entered into strategic partnerships with cardiovascular-r...
HEALTH Magazine's Beyond Pink Event Brings Experts and Survivors Together to Spotlight Women's Health in the UAE
28 November 2025 - Beyond Pink welcomed healthcare professionals, cancer survivors and community figures for an evening focused on wellness, awareness and preventative care for women. Taking place at ...
Gan & Lee Pharmaceuticals launches third phase 3 trial of once-monthly bofanglutide
27 November 2025 - Chinese biopharmaceutical company Gan & Lee Pharmaceuticals Co., Ltd. (SHA: 603087) announced on Thursday that it has begun GRADUAL-3, its third large-scale phase 3 study of the...
Remington Medical's VascuChek 2.0 Cordless Bluetooth-Enabled Doppler Secures FDA Clearance
26 November 2025 - Remington Medical has confirmed that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its updated VascuChek® Doppler, marking the official commercial...
LivaNova secures higher Medicare reimbursement for VNS Therapy procedures
24 November 2025 - Medical technology company LivaNova PLC (Nasdaq: LIVN) announced that the U.S. Centers for Medicare & Medicaid Services (CMS) will assign VNS Therapy for drug-resistant epilepsy...